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Summary
Objective: Cartilage destruction in osteoarthritis (OA) is associated with increased levels of several matrix metalloproteinases (MMPs),
including the gelatinases MMP-2 and MMP-9. While increases in some MMPs may be destructive, up-regulation of others may result from
increases in normal tissue turnover. The production of MMP-2 and MMP-9 by the anabolic transforming growth factor beta-1 (TGF-1) in
normal equine chondrocytes was investigated.
Design: Equine chondrocytes from clinically normal femoropatellar joints were maintained in alginate beads. After serum deprivation, cells
were exposed to TGF-1 at several concentrations for varying times. Activities of MMP-2 and MMP-9 were estimated by gelatin zymography,
while mRNA for MMP-2, MMP-9 and collagen type II were detected using reverse transcription-polymerase chain reaction.
Results: Stimulation with TGF-1 differentially regulated MMP-2 and MMP-9, with strong up-regulation of both MMP-9 mRNA and enzyme.
Increases in MMP-9 enzyme were dose-dependent (0–49 h). There is some evidence suggesting a slight reduction in MMP-2 release
following stimulation. Collagen type II mRNA was transiently increased following stimulation.
Conclusions: The different effects of TGF-1 on MMP-2 and MMP-9 production by normal chondrocytes suggests different roles for these
enzymes. The increases in both MMP-9 and collagen type II mRNA following stimulation may suggest a role for MMP-9 in tissue
maintenance. Therefore, increased MMP-9 may be secondary to, as distinct from a cause of, cartilage damage. © 2001 OsteoArthritis
Research Society International
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Osteoarthritis (OA) is a degenerative condition resulting in
loss of articular cartilage which, in severe cases, can result
in full-thickness cartilage erosions with accompanying
severe pain and disability. The mechanisms leading to
cartilage loss are poorly understood, although much atten-
tion has focused on the involvement of members of the
matrix metalloproteinase (MMP) family of zinc- and
calcium-dependent endopeptidases1. Most extracellular
matrix components are substrates for at least one MMP
and there is now a consensus that these enzymes are
essential for normal extracellular matrix remodeling and
maintenance. Most MMPs are secreted as proenzymes
which can be activated by removal of the propeptide region.
Their activity is further regulated by non-covalent binding to
one of a number of tissue inhibitors of metalloproteinases
(TIMPs)2.
Much evidence exists to show an association between
OA and MMPs3. Increased levels of several MMPs have
been found in OA joints, both in synovial fluid and in325cartilage itself. These include collagenase-1 and -3
(MMP-1 and MMP-13 respectively)4, stomelysin-1 (MMP-
3)5, membrane type-1 MMP (MT1-MMP)6 and the gelati-
nases, MMP-9 and MMP-27,8. The classification of MMP-2
and MMP-9 as gelatinases is arbitrary and both can
degrade many substrates, including collagens type IV, V,
VII, X and the cartilage-specific type XI9,10. They can also
degrade aggrecan core protein in vitro although evidence
suggests that a collagenase-type MMP is responsible for
proteoglycan degradation within cartilage explants11. How-
ever, evidence that gelatinases may be significant in the
degradation of collagen was demonstrated by Kozaci
et al.12 who showed that collagen loss from cartilage could
be prevented by the use of a specific gelatinase MMP
inhibitor.
The specific signals that control MMPs in cartilage are
unknown. However, many growth factors have been ident-
ified that play central roles in regulating articular cartilage
metabolism13, including the production of some MMPs.
Transforming growth factor beta (TGF-) is perhaps the
most widely studied of such factors. There are at least three
isoforms of TGF- (TGF-1, TGF-2 and TGF-3), which
themselves comprise a subfamily within a wider group of
structurally related polypeptide growth factors14. TGF- is
widely distributed and its effects differ greatly depending on
tissue and cell type. With chondrocytes, differing TGF-
effects have been observed on both proteoglycan synthesis
and proliferation depending on the culture system used13.
TGF-1 has been shown to up-regulate collagen synthesis
in primary monolayer cultures of rabbit articular chondro-
cytes15. Differential regulation of collagenases following
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human chondrocytes isolated from areas close to and
distant from OA lesions16. MMP-1, MMP-8 and MMP-13
were all down-regulated by TGF-1 in lesion-derived
chondrocytes, while cells from areas distant from the lesion
had decreased MMP-1 and MMP-8 but increased MMP-13.
In addition to increased MMP levels, OA cartilage also
displays increased synthesis of both collagens and
proteoglycans17–19, showing that chondrocytes are ca-
pable of responding to damage. Despite such anabolic
responses, net matrix loss still occurs and up-regulated
MMP activities could account for such an outcome. The
increased levels of some MMPs may be due to an abnor-
mally rapid tissue turnover. While the normal roles of MMPs
in cartilage are not well understood, it is possible that some
may be produced concurrent with synthesis of matrix
components, possibly acting to remove degraded or dam-
aged material prior to the integration of the new material
into undamaged matrix. Such repair and maintenance
processes exist and gelatinases may be involved, given
their ability to digest many matrix components, including in
particular, denatured collagen.
The present study was directed towards studying the
production of MMP-9 and MMP-2 in normal cultured equine
chondrocytes following TGF-1 stimulation. Production of
collagen type II mRNA was used as an indicator of
response by chondrocytes. Our results showed differential
regulation of MMP-9 and MMP-2 by TGF-1 stimulation of
chondrocytes.Method
MATERIALS
Full-thickness cartilage was obtained from clinically nor-
mal femoropatellar joints of horses killed for reasons other
than joint disease. All samples were from skeletally mature
horses aged between 3 and 7 years. Recombinant human
TGF-1 (rhTGF-1), DMEM (with sodium pyruvate and
1 g/l glucose), fetal bovine serum (FBS), gentamicin,
amphotericin B, bacterial collagenase (type II) and Trizol
reagent were from Life Technologies (Paisley, Scotland,
U.K.). Reagents for reverse transcription were also from
Life Technologies, with the exception of RNase-free DNase
I and recombinant human RNase inhibitor, which were from
Promega (Southampton, U.K.). Low viscosity sodium algi-
nate, bovine serum albumin (BSA; fraction V) and gelatin
(from bovine skin) were from Sigma (Dorset, U.K.). Other
chemicals were of reagent grade quality.ALGINATE BEAD CHONDROCYTE CULTURES
Chondrocytes were isolated by overnight digestion of
cartilage slices, pooled from left and right femoropatellar
joints, with gentle stirring at 37°C, in serum-free DMEM
containing 50 g/ml gentamicin, 2.5 g/ml amphotericin B
and 0.1% w/v bacterial collagenase. Undigested material
was allowed to settle before decanting the supernatant into
centrifuge tubes. Cells were pelleted at 250 g for 10 min,
pooled, and washed three times in 0.15 M NaCl. They were
then resuspended in 10 ml 0.15 M NaCl, counted using a
hemocytometer, and pelleted. Typically, between 10×106
and 15×106 cells were obtained. Encapsulation of cells in
alginate was performed according to the method of Guo et
al.20 Cells were resuspended in 1.2% w/v sodium alginate
in 0.15 M NaCl at a concentration of 3×106/ml. The sus-pension was expressed dropwise through a 21 gauge
needle into a solution of 100 mM CaCl2. The beads were
incubated in this solution for 10–15 min to allow complete
gelling of the alginate. They were then washed three times
in 0.15 M NaCl and once in DMEM containing 10% FBS,
gentamicin and amphotericin B (‘complete medium’). All
washes were for 10 min at room temperature with gentle
mixing, in volumes of solutions at least 10 times that of the
beads. The beads were then transferred to a 10×10 cm
dish and 35 ml of complete medium added. Cultures were
maintained at 37°C in a 5% CO2-in-air atmosphere, with
replacement of complete medium every 2 days.STIMULATION OF CELLS WITH TGF-1
Sufficient beads were transferred to a new dish 24 h prior
to stimulation and 35 ml of serum-free medium added. To
ensure adequate removal of serum factors within the beads
themselves, cultures were incubated at 37°C for 3–4 h in
this medium before replacing it with fresh serum-free
medium for the remaining time prior to stimulation. Beads
were transferred to a 24-well dish for stimulation. For each
experiment, equal numbers of beads (between eight and
10) were used per well. Excess medium transferred with
the beads was removed and 1 ml of serum-free DMEM
containing 0.1% w/v bovine serum albumin and the appro-
priate concentration of rhTGF-1 was added. Samples of
medium were removed after the required period of incu-
bation and the beads were then disrupted by repeated
pipetting in 1.3 ml of Trizol reagent. Both media and Trizol
samples were stored at −70°C until required.PREPARATION OF TOTAL RNA AND cDNA
Total RNA was prepared from the Trizol samples accord-
ing to the manufacturer’s protocol. The RNA pellet was
dissolved in water and the RNA concentration estimated by
measurement of absorbance at 260 nm. Conversion of
total RNA to single-stranded cDNA included reduction of
contaminating genomic DNA by DNase I digestion by a
modification of the method of Huang et al.21. After initial
heat denaturation of the RNA along with 500 ng
oligo(dT)12–18, in a volume of 10 l, at 70°C for 10 min
followed by cooling on ice, first strand buffer, DTT, dNTPs,
20U RNase inhibitor and 1U RNase-free DNase I were
added and incubated at 37°C for 50 min. DNase was
inactivated by heating the mix to 75°C for 5 min, before
addition of 200 U of Superscript II reverse transcriptase
and an additional 20 U of RNase inhibitor. This mix was
then incubated at 42°C for 50 min before inactivation of the
reverse transcriptase by heating at 70°C for 15 min. Total
reaction volume was 20 l with final concentrations in 1X
first-strand buffer of 5 mM DTT and 500 M of each dNTP.POLYMERASE CHAIN REACTION (PCR)
Primers for MMP-2 (5′-CAG ATC ACA TAC AGG ATC
ATC G-3′ and 5′-GTC GGC GTT GCC ATA CTT CAC A-3′,
product size 321 bp) were designed from a partial equine
sequence cloned in our laboratories22 (Genbank accession
number AJ010314). Collagen type II primers (5′-AGA TCG
AGA GCA TCC GCA GC-3′ and 5′-GCA GCC ATC CTT
CAG GAC AG-3′, 521 bp) were designed from an equine
sequence (U62528), while those for MMP-9 (5′-GAC ATY
GTC ATC CAG TTT GG-3′ and 5′-GTA GAG TCT YTC RCT
RGG GC-3′, where Y=T or C and R=A or G, 339 bp) were
designed from a consensus sequence derived from mouse,
cow and human (X72795, X78324 and J05070 respect-
ively). PCR reactions were carried out in 50 l volumes
containing 1 l cDNA in a buffer of 1X Qiagen HotStarTaq
PCR buffer (containing 1.5 mM MgCl2), 200 M of each
dNTP, 0.5 M of each primer and 1.25 U of HotStarTaq
DNA polymerase. PCR ampliﬁcation was preceded by an
incubation at 95°C for 15 min to activate the polymerase,
followed by 30–35 cycles of 94°C for 1 min, 55°C for 1 min
and 72°C for 1 min, followed by a ﬁnal extension at 72°C for
15 min. Aliquots of PCR reactions were electrophoresed on
1.5% w/v agarose gels containing 0.5 g/ml ethidium bro-
mide, in TAE buffer (40 mM Tris-acetate; 1 mM EDTA,
pH 8.3). Products were visualized on a U.V. transilluminator
and photographed.
ZYMOGRAPHIC DETERMINATION OF MMP-2 AND MMP-9
Zymography was performed essentially according to the
method of Kleiner and Stetler-Stevenson23. Brieﬂy, 10 l
aliquots of sample, mixed with a 5X loading buffer (625 mM
Tris.Hcl, pH 6.8; 5% SDS; 0.05% bromophenol blue; 10%
v/v glycerol) and incubated at 37°C for 30 min, were
electrophoresed on a 7.5% SDS-PAGE gel containing
1 mg/ml gelatin. Following electrophoresis, the gel was
incubated in 2.5% v/v Triton X-100 for 1 h at room tempera-
ture, washed with water and incubated in a reactivation
buffer (50 mM Tris.HCl; 50 mM CaCl2; 0.05% v/v Brij 35;
pH 7.8) at 37°C for 18 h before staining with a colloidal
Coomassie blue stain. Gels were imaged by scanning at
400 dpi on a UMAX ﬂatbed scanner. Estimates of band
intensities were obtained by analysis of scanned images
using the gel plotting macro supplied with the NIH Image
software package, version 1.61 (available from the US
National Institutes of Health, on the Internet at http://
rsb.info.nih.gov/nih-image/).
Results
We investigated the effects of rhTGF-1, on the produc-
tion of MMP-2 and MMP-9 and on the mRNA levels of
MMP-2, MMP-9 and type II collagen, by normal equine
chondrocytes cultured in alginate. Chondrocytes were
embedded in alginate directly after their release from
cartilage by collagenase digestion and maintained by
medium replacement for periods of between 2 and 6 weeks
prior to their use in experiments. Since responses to growth
factors often vary with time, we examined the time course,
in addition to the dose-dependency, of the responses to
TGF-1.
DOSE-DEPENDENCY OF TGF-1 REGULATION OF GELATINASES
AND TYPE II COLLAGEN
Figure 1 shows the effects of a range of TGF-1 concen-
trations (0, 0.1, 0.5, 2.5 and 12.5 ng/ml) on MMP-2 and
MMP-9 enzyme released into the medium and determined
by zymography [Fig. 1(a)]. Also shown are gels from
RT-PCR reactions for MMP-2, MMP-9 and type II collagen
[Fig. 1(b)]. Results are shown for three separate cultures
Fig. 1. Effects of TGF-1 on chondrocyte production of MMP-9, MMP-2 and type II collagen. Alginate chondrocyte beads were cultured with
concentrations of 0,0.1,0.5,2.5 and 12.5 ng/ml TGF-1 for 24 h. (a) Gelatin zymography showing MMP-9 and MMP-2 enzyme activities in
culture medium. Data represents combined values for the pro and active forms of each enzyme. (b) RT-PCR agarose gels showing MMP-9,
MMP-2 and collagen type II mRNA.
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TGF-1. Beads were transferred to multiwell dishes at the
start of the stimulation period and fresh medium containing
TGF-1 added. Thus, zymographic results represent
release of gelatinases from the beads into the culture
medium over a 24 h period. Release of MMP-9 following
stimulation was dose-dependently increased in all cultures,
with a response observed at the lowest dose of 0.1 ng/ml in
two cultures [Fig. 1(a); cultures B and C] and maximal
effects apparent at doses between 0.5 and 12.5 ng/ml.
MMP-2 release was decreased in all three cultures. The
dose–response profile of this down-regulation was similar
to that for MMP-9.
Messenger RNA levels for MMP-9, determined by
RT-PCR, suggest an up-regulation in all cultures [Fig. 1(b)].
No consistent effect was observed with MMP-2 RT-PCR,
although it is clearly important to note that non-quantitative
RT-PCR, as used in this study, cannot give reliable indica-
tions of relatively small differences in mRNA levels. For
cultures B and C in Fig. 1(b), levels of type II collagen
mRNA were increased, with little up-regulation observed for
culture A.Fig. 2. The effects of the duration of exposure to TGF-1 on MMP-9, MMP-2 and type II collagen production. Chondrocytes were cultured
with TGF-1 for 24 and 48 h. (a) Zymogram showing MMP-9 and MMP-2. (b) RT-PCR gels for MMP-9, MMP-2 and type II collagen mRNA.
(c) Plots of MMP-9 and MMP-2 enzyme derived from the zymogram.TIME-DEPENDENCY OF TGF-1 REGULATION OF GELATINASES AND
TYPE II COLLAGEN
The effects of an increased duration of exposure to
TGF-1 from 24 h to 48 h are shown in Fig. 2. There was a
considerable increase in MMP-9 release between 24 and
48 h [Fig. 2(a), (c)], with a similar dose-dependency in each
case. However, in contrast to the results shown in Fig. 1, no
reduction in MMP-2 was apparent after 24 h in this exper-
iment. Decreased release of MMP-2 was seen after 48 h. In
unstimulated samples, there was an increase in the amount
of each gelatinase released into the medium between 24
and 48 h [Fig. 2(c); points for zero TGF-1]. This was
particularly evident for MMP-9, for which the unstimulated
48 h medium sample contained more MMP-9 than the
sample with most MMP-9 after 24 h (12.5 ng/ml). Thus,
chondrocytes secrete both MMP-9 and MMP-2 during
serum-deprivation. Levels of mRNA for MMP-9, MMP-2
and type II collagen are shown in Fig. 2(b). After both 24
and 48 h, there was an increase in MMP-9 mRNA levels,
while for MMP-2 no consistent effect was observed,
although band intensities did vary. Type II collagen mRNA
was up-regulated following stimulation at all concentrations
of TGF-1 after 24 h. No signal was observed at any
concentration after 48 h stimulation. Included in this exper-
iment were cells cultured in DMEM containing FBS, but
with no rhTGF-1 [Fig. 2(a), (b); ‘+FCS’ lanes]. These are
equivalent to the unstimulated samples, but without serum
deprivation. FBS contains high levels of gelatinases and
consequently the zymographic ﬁndings cannot distinguish
between FBS- and chondrocyte-derived activities. Figure
2(b) shows that serum-deprivation causes a reduction
in the amount of type II collagen mRNA, but has no
observable effect on MMP-9 or MMP-2 mRNA levels.
A time-course experiment (Fig. 3) examined MMP-9,
MMP-2 and type II collagen at 6, 12, 24 and 49 h following
exposure to either no growth factor or to 12.5 ng/ml TGF-
1, a dose which elicited near-maximal responses in other
experiments. In unstimulated samples, levels of both
MMP-9 and MMP-2 released into the medium increased
with time [Fig. 3(a)]. Exposure to TGF-1 caused an
elevation in MMP-9 above unstimulated levels from 12 h
onwards, while for MMP-2, stimulation caused a small
inhibition of the increases seen with no TGF-1. Stimulated
MMP-9 RT-PCR band intensities increased with time, sug-
gesting a time-dependent increase in mRNA levels, while
relatively small differences were seen for MMP-2 [Fig. 3(b)].
Type II collagen mRNA levels were transiently increased
following stimulation [Fig. 3(b); 0 h lane], suggesting that
type II collagen levels were not down-regulated after the
24 h serum-deprivation which preceded stimulation.
Discussion
In this study we examined gelatinase regulation by
TGF-1 in alginate bead cultures of normal equine
chondrocytes. The alginate culture system was chosen
since previous work has shown that articular chondrocytes
in alginate have a similar biochemical phenotype to those
within intact cartilage, with respect to the types and propor-
tions of collagens24 and proteoglycans25 produced. This is
the case even for chondrocytes which were pre-cultured as
monolayers, during which time expression of cartilage-
speciﬁc genes is reduced26. Alginate cultures are also
relatively stable, with retention of chondrocytic phenotype
for periods of at least several months27. The alginate
system, therefore, has many advantages over the use of
chondrocyte monolayers which have many ﬁbroblastic
characteristics, including the production of large amounts
of type I collagen, which is normally present in extremely
low amounts in normal cartilage26.
The key ﬁnding in this study is the differential regulation,
by TGF-1, of MMP-9 and MMP-2 production by normal
equine chondrocytes. Much previous work on cartilage
metabolism suggests an anabolic role for TGF- stimu-
lation of chondrocytes, including increased chondrocyte
production of proteoglycans28 and type II collagen15. Also,
TGF-1 antagonizes the catabolic effect that interleukin-1
has on cartilage matrix synthesis29. The anabolic effects of
TGF-1 were conﬁrmed in this study, by the up-regulation
of type II collagen mRNA expression. It is therefore para-
doxical that TGF-1 up-regulated production of MMP-9, an
enzyme which clearly breaks down matrix components.
One possible explanation is that the degradative function of
MMP-9 operates in conjunction with matrix production as
part of a matrix turnover and repair process. Such a role
has not been identiﬁed for MMP-9. However, it is feasible
that efficient degradation and removal of already compro-
mised cartilage matrix, either before or concurrent with the
laying down of new cartilage components, may form a part
Fig. 3. Time course of induction of MMP-9, MMP-2 and type II collagen. Cells were cultured with 0 or 12.5 ng/ml TGF-1 for the times
indicated. (a) Histograms of MMP-9 and MMP-2 enzyme activities. (b) RT-PCR gels for MMP-9, MMP-2 and type II collagen.
Osteoarthritis and Cartilage Vol. 9, No. 4 329
330 C. C. M. Thompson et al.: Effects of TGF-1 on chondrocyte gelatinasesof a matrix repair process. MMP-9 could be required for this
function. There could be some other anabolic processes for
which MMP-9 is required, but none has yet been identified.
Given that TGF-1 stimulation causes a clear increase in
the amount of mRNA for MMP-9, and in the production of
enzyme, it seems likely that the increase in enzyme is due,
at least in part, to increased synthesis by chondrocytes, as
distinct from a simple release of stored intracellular
enzyme. There was a much smaller and less repeatable
inhibitory effect of TGF-1 on MMP-2. It is unclear from the
present work whether the slight reduction in MMP-2 release
from beads into the culture medium is significant. Reduc-
tions in MMP-2 release may be due to a direct effect on
production and secretion of this enzyme by chondrocytes.
Our data were unable to provide evidence for such a direct
effect. However, the results presented represent MMP-2
released from the alginate beads into tissue culture
medium and an alternative explanation for decreased
MMP-2 levels in the medium could be increased MMP-2
retention by the bead. This could occur, for example, as a
consequence of MMP-2 binding to insoluble matrix compo-
nents. Alternatively, there could be increased association of
MMP-2 with TIMPs, predominantly TIMP-2. MMP-2:TIMP
complexes would be substantially larger than the enzyme
on its own and would consequently diffuse less readily out
of the bead. Such retention could account for decreased
MMP-2 levels in the medium of stimulated cultures despite
similar amounts being produced by the chondrocytes in
both stimulated and unstimulated cultures. Attempts to
study MMP-2 and MMP-9 within beads by zymography
demonstrated some retained gelatinases but due to severe
smearing of bands, quantitative comparison between
samples was impossible (data not shown). Physical entrap-
ment of secreted products, such as gelatinase MMPs,
could also occur within cartilage matrix, particularly when
complexed to TIMPs. This is an area of research which
justifies further study.
Since MMPs and TIMPs appear to act together to
regulate much of the degradative activity in cartilage (and
other extracellular matrices)2, an increase in MMP-9 pro-
duction by chondrocytes may not in itself lead to an
increase in degradative activity. Additionally, most of the
increased MMP-9 production was in the pro-MMP-9 form.
Activation of this, by removal of the pro-peptide region is
considered to be required for enzyme activity. One study on
cartilage has shown an association between MMP-9 mRNA
levels and areas of fibrillation on OA cartilage;8 MMP-9 was
virtually undetectable in normal cartilage. This suggests
that MMP-9 enzyme may also be present in increased
amounts in such regions of damaged matrix, although it
gives no indication of its function.
The signals that cause changes in MMPs and other
effectors within intact cartilage in vivo are generally
unknown. In the case of MMP-9 up-regulation, our findings
suggest that TGF-1 must be considered a candidate
growth factor capable of causing such a response. How-
ever, other factors also alter gelatinase production; in a
study of normal human cartilage, interleukin-1 treatment
caused similar changes to those found in our study, i.e. an
increase in MMP-9 mRNA, with no change in MMP-2
mRNA7. Other factors, currently unidentified, but which
may include physical as well as biochemical mediators,
may also elicit similar responses. Indeed, since chondro-
cytes are highly differentiated and specialized cells, which
function primarily to synthesize and maintain cartilage, it
could be assumed that the effects of TGF-1 shown in this
study are therefore important in cartilage matrix integrity.The more we understand about the effects of growth
factors, the better we will be able to explain how the
processes are subverted in disease.References
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